ScreenPro Security Inc. provided testing revenue guidance for the year 2022. Due to the Company's focus in the film industry, strong testing revenue is expected in 2022 as the Company does not foresee change in processes in the near term in the film industry.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -50.00% | -.--% | -66.67% |
05-23 | Justera Health Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-22 | Justera Health Ltd. Announces Board Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-66.67% | 589K | |
-7.16% | 178B | |
-1.23% | 107B | |
-4.86% | 67.04B | |
-4.28% | 47.23B | |
+10.32% | 44.62B | |
+8.14% | 42.5B | |
+15.53% | 25.22B | |
-5.88% | 24.14B | |
-5.38% | 23.69B |
- Stock Market
- Equities
- VTAL Stock
- News Justera Health Ltd.
- ScreenPro Security Inc. Provides Testing Revenue Guidance for the Year 2022